首页> 美国卫生研究院文献>Journal of Clinical and Diagnostic Research : JCDR >Reproducibility of ‘The Bethesda System for reporting Thyroid Cytopathology’: A MultiCenter Study with Review of the Literature
【2h】

Reproducibility of ‘The Bethesda System for reporting Thyroid Cytopathology’: A MultiCenter Study with Review of the Literature

机译:Bethesda系统报告甲状腺细胞病理学的可重复性:一项多中心研究并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: To achieve the standardization of the thyroid FNA reporting, the National Cancer Institute (NCI) hosted the “NCI Thyroid Fine Needle Aspiration State of the Science Conference”, which led to the formation of ‘The Bethesda System for Reporting Thyroid Cytopathology’ (TBSRTC).>Material and Methods: The present study was undertaken by 2 experts in thyroid FNA, who in a double blinded fashion, examined and re-classified 80 random FNA cases according to the 6 levels of TBSRTC for an inter-observer review, to study and assess the new terminology for ease of reproducibility and to note the rate of disagreement overall or in any particular category. The FNAs were reclassified in a double blinded fashion according to the 6 levels of TBSRTC which are: non diagnostic (ND); benign; atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS); follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN), Hurthle cell type/suspicious for a follicular neoplasm, Hurthle cell type (FNHCT/SFNHCT); suspicious (SUS), and malignant.>Results: In the present study, the maximum number of cases was reclassified under the benign category (61.25% cases), followed by the FN/ SFN category and the AUS/FLUS category (11.25% and 10.00% respectively). An agreement was reached in 66 cases (82.5%); the experts disagreed in 14 cases-17.5% (where 1 expert did not agree with the other). Individually; a 93.87% agreement was noted for the lesions in the benign category, for 50% lesions in the AUS/FLUS category, for 66.66% lesions in the FN/SFN and the SUS categories, for 71.42% lesions in the FNHCT/ SFNHCT categories and for 100% lesions in the ND and the malignant categories. Thus, the maximum disagreement was noted in the AUS/FLUS category.>Conclusion: The implementation of TBSTRC which stands for a unique, international and a universal terminology for reporting the thyroid cytology; should be encouraged in our country, because of its relative ease of reproducibility. Although there was a great deal of agreement in implementing TBSTRC in the present study; disagreements were seen in the categories of AUS/FLUS and FN/SFN in the study which was conducted at our centre. This corroborated with the findings of the studies which were done elsewhere.
机译:>背景:为了实现甲状腺FNA报告的标准化,美国国家癌症研究所(NCI)主办了“ NCI甲状腺细针抽吸科学大会”,从而形成了“贝塞斯达(Bethesda)”甲状腺细胞病理学报告系统(TBSRTC)。>材料与方法:本研究由两名甲状腺FNA专家进行,他们以双盲方式对80例随机FNA病例进行了检查和重新分类。 TBSRTC的6个级别进行观察者之间的审查,以研究和评估新术语以简化可重复性,并指出总体或任何特定类别中的分歧率。根据TBSRTC的6个级别以双盲方式将FNA重新分类:非诊断(ND);良性;意义未定的非典型性/意义未定的卵泡病变(AUS / FLUS);滤泡性肿瘤/可疑滤泡性肿瘤(FN / SFN),荷尔蒙细胞类型/可滤性肿瘤,可疑滤泡性肿瘤,Hurthle细胞类型(FNHCT / SFNHCT); >结果:在本研究中,最大病例数被重新分类为良性类别(61.25%病例),其次是FN / SFN类别和AUS / FLUS类别(分别为11.25%和10.00%)。在66起案件中达成了协议(82.5%);专家不同意14例,占17.5%(其中一位专家不同意另一位专家)。个别地良性类别的病变,AUS / FLUS类别的病变为50%,FN / SFN和SUS类别的病变为66.66%,FNHCT / SFNHCT类别的71.42%病变以及ND和恶性肿瘤中100%的病变。因此,在AUS / FLUS类别中注意到了最大的分歧。>结论: TBSTRC的实现代表了报告甲状腺细胞学的独特,国际和通用术语;应该鼓励在我国,因为它相对容易再现。尽管在本研究中实施TBSTRC达成了许多协议;在我们中心进行的研究中,在AUS / FLUS和FN / SFN类别中存在分歧。这与在其他地方进行的研究结果相佐证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号